Jacob Steven Leach, SVP, Research & Development at DEXCOM INC (DXCM), sold 31,154 shares at $138.32 ($4.3M) on 2018-08-24, disclosed to the SEC on 2018-08-28.
Open-market sale of $4.3M DXCM by SVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.32 | 10,000 | $1.4M | 32.1% |
| 2 | $138.32 | 10,577 | $1.5M | 34.0% |
| 3 | $138.32 | 10,577 | $1.5M | 34.0% |
| Total | $138.32 avg | 31,154 | $4.3M | 100% |
| Filing → |
| DXCM | SELL | 2025-03-14 | $2.0M | — | Filing → |
| DXCM | SELL | 2025-01-30 | $458K | — | Filing → |
| DXCM | SELL | 2024-12-17 | $114K | — | Filing → |